JP Morgan Chase’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,500
Closed -$460K 7692
2024
Q1
$460K Buy
+2,500
New +$476K ﹤0.01% 4855
2022
Q4
Sell
-7,700
Closed -$1.44M 6919
2022
Q3
$1.44M Buy
+7,700
New +$1.62M ﹤0.01% 3738

Other funds holding RGEN

JP Morgan Chase's RGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Repligen (RGEN) stake by 48% in Q1 2026, selling an estimated $16.9M and leaving 128,221 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.

JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 44 quarters since. The position peaked at $98.2M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • JP Morgan Chase held 128,221 shares of Repligen worth $14.3M as of Q1 2026.
  • JP Morgan Chase sold 120,716 Repligen shares in Q1 2026, an estimated $16.9M.
  • Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2374 holding.
  • JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 44 quarters since.
  • JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.